Red genetically encoded calcium indicators and methods of use

US2016176931A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016176931-A1
Application numberUS-201514974483-A
CountryUS
Kind codeA1
Filing dateDec 18, 2015
Priority dateDec 23, 2014
Publication dateJun 23, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Protein indicators useful for calcium imaging, in particular, red genetically-encoded calcium indicators (GECIs) disclosed herein rival best-of-class green GECIs in terms of sensitivity for detecting neural activity, and can be monitored in vivo. The presently-disclosed subject matter further includes a method of monitoring cell activity comprising stimulating a cell comprising a red GECI polypeptide; and detecting fluorescence emitted by the cell.

First claim

Opening claim text (preview).

We claim: 1 . A nucleic acid molecule comprising a sequence that encodes a genetically encoded calcium indicator (GECI) polypeptide having at least 95% sequence identity to SEQ ID NO:2 or SEQ ID NO:4. 2 . The nucleic acid molecule of claim 1 , comprising a sequence that encodes a GECI polypeptide having at least 99% sequence identity to SEQ ID NO:2 or SEQ ID NO:4. 3 . The nucleic acid molecule of claim 1 , comprising a sequence that encodes a GECI polypeptide consisting of the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:4. 4 . A vector comprising the nucleic acid molecule of claim 1 . 5 . A cell comprising the vector of claim 4 . 6 . A cell comprising the nucleic acid molecule of claim 1 . 7 . A nucleic acid molecule comprising the sequence of SEQ ID NO:1 or SEQ ID NO:3. 8 . A vector comprising the nucleic acid molecule of claim 7 . 9 . A polypeptide comprising a GECI polypeptide sequence having at least 95% sequence identity to SEQ ID NO:2 or SEQ ID NO:4. 10 . The polypeptide of claim 9 , wherein the polypeptide comprises a GECI polypeptide sequence having at least 99% sequence identity to SEQ ID NO:2 or SEQ ID NO:4. 11 . The polypeptide of claim 9 , wherein the polypeptide comprises the sequence of SEQ ID NO:2 or SEQ ID NO:4. 12 . A cell comprising the polypeptide of claim 9 . 13 . A method of monitoring the activity of a cell, comprising: (i) stimulating a cell comprising a polypeptide of claim 9 ; and (ii) detecting fluorescence emitted by the cell. 14 . The method of claim 13 , wherein the cell is in a biological sample from a subject. 15 . The method of claim 14 , wherein the steps are performed in vivo. 16 . The method of claim 15 , wherein the subject is a mouse, a fish, a worm or a fly. 17 . The method of claim 16 , wherein the subject is a mouse and the cell is in the primary visual cortex. 18 . The method of claim 16 , wherein the cell is a motor neuron with terminals in the neuro-muscular junction (NW), a trigeminal neuron, or an ASH neuron. 19 . The method of claim 13 , wherein the detecting step comprises imaging. 20 . The method of claim 13 , wherein the cell is a neuronal cell, a muscle cell or a cardiomyocyte. 21 . A nucleic acid molecule comprising a sequence that encodes a genetically encoded calcium indicator (GECI) polypeptide having at least 95% sequence identity to SEQ ID NO:6. 22 . The nucleic acid molecule of claim 21 , comprising a sequence that encodes a GECI polypeptide having at least 99% sequence identity to SEQ ID NO:6. 23 . The nucleic acid molecule of claim 1 , comprising a sequence that encodes a GECI polypeptide consisting of the amino acid sequence of SEQ ID NO:6. 24 . A vector comprising the nucleic acid molecule of claim 21 . 25 . A cell comprising the vector of claim 24 . 26 . A cell comprising the nucleic acid molecule of claim 21 . 27 . A nucleic acid molecule comprising the sequence of SEQ ID NO:5. 28 . A vector comprising the nucleic acid molecule of claim 27 . 29 . A polypeptide comprising a GECI polypeptide sequence having at least 95% sequence identity to SEQ ID NO:6. 30 . The polypeptide of claim 29 , wherein the polypeptide comprises a GECI polypeptide sequence having at least 99% sequence identity to SEQ ID NO:6. 31 . The polypeptide of claim 29 , wherein the polypeptide comprises the sequence of SEQ ID NO:6. 32 . A cell comprising the polypeptide of claim 29 . 33 . A method of monitoring the activity of a cell, comprising: (i) stimulating a cell comprising a polypeptide of claim 29 ; and (ii) detecting fluorescence emitted by the cell.

Assignees

Inventors

Classifications

  • Calcium binding proteins, e.g. calmodulin · CPC title

  • the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo · CPC title

  • C07K14/001Primary

    by chemical synthesis · CPC title

  • involving analysis of members of signalling pathways · CPC title

  • viral genome or elements thereof as genetic vector · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016176931A1 cover?
Protein indicators useful for calcium imaging, in particular, red genetically-encoded calcium indicators (GECIs) disclosed herein rival best-of-class green GECIs in terms of sensitivity for detecting neural activity, and can be monitored in vivo. The presently-disclosed subject matter further includes a method of monitoring cell activity comprising stimulating a cell comprising a red GECI polyp…
Who is the assignee on this patent?
Hughes Howard Med Inst
What technology area does this patent fall under?
Primary CPC classification C07K14/001. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jun 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).